Identification of sialylated glycoproteins in doxorubicin-treated hepatoma cells with glycoproteomic analyses

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4869-4877

  Azuma, Kanako ^a   Serada, Satoshi ^b   Takamatsu, Shinji ^a   Terao, Naoko ^a   Takeishi, Shunsaku ^c   Kamada, Yoshihiro ^a   Naka, Tetsuji ^b   Miyoshi, Eiji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

cancer stem cells; doxorubicin; glycoproteomics; hepatoma; sialylation

Indexed keywords

BETA GALACTOSIDASE; DOXORUBICIN; FETUIN A; LECTIN; SAMBUCUS SIEBOLDOANA AGGLUTININ; SIALOGLYCOPROTEIN; UNCLASSIFIED DRUG; AGGLUTININ; GLYCOPROTEIN; SIALIC ACID DERIVATIVE;

ARTICLE; CANCER STEM CELL; CELL SUBPOPULATION; CONTROLLED STUDY; HEPATOCELLULAR CARCINOMA CELL LINE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PRECIPITATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; QUANTITATIVE ANALYSIS; SIALYLATION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; CARCINOMA, HEPATOCELLULAR; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; METABOLISM; NONPARAMETRIC TEST; PROCEDURES; TUMOR CELL LINE;

AGGLUTININS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DOXORUBICIN; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; LECTINS; LIVER NEOPLASMS; MICROSCOPY, FLUORESCENCE; NEOPLASTIC STEM CELLS; PROTEOMICS; SIALIC ACIDS; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY;

EID: 84908892406     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5004399     Document Type: Article

References (47)

1. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells Nature 2001, 414 (6859) 105-11
2. Ailles, L. E.; Weissman, I. L. Cancer stem cells in solid tumors Curr. Opin. Biotechnol. 2007, 18 (5) 460-6
3. Mertins, S. D. Cancer stem cells: a systems biology view of their role in prognosis and therapy Anticancer Drugs 2014, 25 (4) 353-67
4. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance Nat. Rev. Cancer 2005, 5 (4) 275-84
5. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006, 444 (7120) 756-60
6. Malik, B.; Nie, D. Cancer stem cells and resistance to chemo and radio therapy Front. Biosci., Elite Ed. 2012, 4, 2142-9
7. Baumann, M.; Krause, M.; Thames, H.; Trott, K.; Zips, D. Cancer stem cells and radiotherapy Int. J. Radiat. Biol. 2009, 85 (5) 391-402
8. Haraguchi, N.; Ishii, H.; Mimori, K.; Tanaka, F.; Ohkuma, M.; Kim, H. M.; Akita, H.; Takiuchi, D.; Hatano, H.; Nagano, H.; Barnard, G. F.; Doki, Y.; Mori, M. CD13 is a therapeutic target in human liver cancer stem cells J. Clin. Invest. 2010, 120 (9) 3326-39
9. Zhu, Z.; Hao, X.; Yan, M.; Yao, M.; Ge, C.; Gu, J.; Li, J. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma Int. J. Cancer 2010, 126 (9) 2067-78
10. Yang, Z. F.; Ho, D. W.; Ng, M. N.; Lau, C. K.; Yu, W. C.; Ngai, P.; Chu, P. W.; Lam, C. T.; Poon, R. T.; Fan, S. T. Significance of CD90+ cancer stem cells in human liver cancer Cancer Cell 2008, 13 (2) 153-66
11. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7) 3983-8
12. Kojima, K.; Musch, M. W.; Ren, H.; Boone, D. L.; Hendrickson, B. A.; Ma, A.; Chang, E. B. Enteric flora and lymphocyte-derived cytokines determine expression of heat shock proteins in mouse colonic epithelial cells Gastroenterology 2003, 124 (5) 1395-407
13. Ding, W.; Mouzaki, M.; You, H.; Laird, J. C.; Mato, J.; Lu, S. C.; Rountree, C. B. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis Hepatology 2009, 49 (4) 1277-86
14. Fuster, M. M.; Esko, J. D. The sweet and sour of cancer: glycans as novel therapeutic targets Nat. Rev. Cancer 2005, 5 (7) 526-42
15. Haltiwanger, R. S.; Lowe, J. B. Role of glycosylation in development Annu. Rev. Biochem. 2004, 73, 491-537
16. Moriwaki, K.; Okudo, K.; Haraguchi, N.; Takeishi, S.; Sawaki, H.; Narimatsu, H.; Tanemura, M.; Ishii, H.; Mori, M.; Miyoshi, E. Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity Cancer Sci. 2011, 102 (6) 1164-70
17. Varki, A. Sialic acids in human health and disease Trends Mol. Med. 2008, 14 (8) 351-60
18. Yogeeswaran, G.; Salk, P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines Science 1981, 212 (4502) 1514-6
19. Fogel, M.; Altevogt, P.; Schirrmacher, V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation J. Exp. Med. 1983, 157 (1) 371-6
20. Passaniti, A.; Hart, G. W. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures J. Biol. Chem. 1988, 263 (16) 7591-603
21. Cui, H.; Lin, Y.; Yue, L.; Zhao, X.; Liu, J. Differential expression of the alpha2,3-sialic acid residues in breast cancer is associated with metastatic potential Oncol. Rep. 2011, 25 (5) 1365-71
22. Babal, P.; Janega, P.; Cerna, A.; Kholova, I.; Brabencova, E. Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation Acta Histochem. 2006, 108 (2) 133-40
23. Sethi, M. K.; Thaysen-Andersen, M.; Smith, J. T.; Baker, M. S.; Packer, N. H.; Hancock, W. S.; Fanayan, S. Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and alpha-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines J. Proteome Res. 2014, 13 (1) 277-88
24. Lanctot, P. M.; Gage, F. H.; Varki, A. P. The glycans of stem cells Curr. Opin. Chem. Biol. 2007, 11 (4) 373-80
25. Taniguchi, N.; Ekuni, A.; Ko, J. H.; Miyoshi, E.; Ikeda, Y.; Ihara, Y.; Nishikawa, A.; Honke, K.; Takahashi, M. A glycomic approach to the identification and characterization of glycoprotein function in cells transfected with glycosyltransferase genes Proteomics 2001, 1 (2) 239-47
26. Hermann, P. C.; Huber, S. L.; Herrler, T.; Aicher, A.; Ellwart, J. W.; Guba, M.; Bruns, C. J.; Heeschen, C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 2007, 1 (3) 313-23
27. Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Mol. Cell Proteomics 2004, 3 (12) 1154-69
28. Zieske, L. R. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies J. Exp. Bot 2006, 57 (7) 1501-8
29. Kuno, A.; Uchiyama, N.; Koseki-Kuno, S.; Ebe, Y.; Takashima, S.; Yamada, M.; Hirabayashi, J. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling Nat. Methods 2005, 2 (11) 851-6
30. Serada, S.; Fujimoto, M.; Ogata, A.; Terabe, F.; Hirano, T.; Iijima, H.; Shinzaki, S.; Nishikawa, T.; Ohkawara, T.; Iwahori, K.; Ohguro, N.; Kishimoto, T.; Naka, T. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases Ann. Rheum. Dis. 2010, 69 (4) 770-4
31. Serada, S.; Fujimoto, M.; Takahashi, T.; He, P.; Hayashi, A.; Tanaka, T.; Hagihara, K.; Yamadori, T.; Mochizuki, M.; Norioka, N.; Norioka, S.; Kawase, I.; Naka, T. Proteomic analysis of autoantigens associated with systemic lupus erythematosus: Anti-aldolase A antibody as a potential marker of lupus nephritis Proteomics Clin. Appl. 2007, 1 (2) 185-91
32. He, P.; Naka, T.; Serada, S.; Fujimoto, M.; Tanaka, T.; Hashimoto, S.; Shima, Y.; Yamadori, T.; Suzuki, H.; Hirashima, T.; Matsui, K.; Shiono, H.; Okumura, M.; Nishida, T.; Tachibana, I.; Norioka, N.; Norioka, S.; Kawase, I. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer Cancer Sci. 2007, 98 (8) 1234-40
33. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal. Chem. 1996, 68 (5) 850-8
34. Kuwamoto, K.; Takeda, Y.; Shirai, A.; Nakagawa, T.; Takeishi, S.; Ihara, S.; Miyamoto, Y.; Shinzaki, S.; Ko, J. H.; Miyoshi, E. Identification of various types of alpha2-HS glycoprotein in sera of patients with pancreatic cancer: Possible implication in resistance to protease treatment Mol. Med. Rep 2010, 3 (4) 651-6
35. Stojadinovic, A.; Hooke, J. A.; Shriver, C. D.; Nissan, A.; Kovatich, A. J.; Kao, T. C.; Ponniah, S.; Peoples, G. E.; Moroni, M. HYOU1/Orp150 expression in breast cancer Med. Sci. Monit 2007, 13 (11) BR231-239
36. Fukuda, M.; Viitala, J.; Matteson, J.; Carlsson, S. R. Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Comparison of their deduced amino acid sequences J. Biol. Chem. 1988, 263 (35) 18920-8
37. Privitera, S.; Prody, C. A.; Callahan, J. W.; Hinek, A. The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein J. Biol. Chem. 1998, 273 (11) 6319-26
38. Eom, Y. W.; Kim, M. A.; Park, S. S.; Goo, M. J.; Kwon, H. J.; Sohn, S.; Kim, W. H.; Yoon, G.; Choi, K. S. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype Oncogene 2005, 24 (30) 4765-77
39. Hayase, T.; Rice, K. G.; Dziegielewska, K. M.; Kuhlenschmidt, M.; Reilly, T.; Lee, Y. C. Comparison of N-glycosides of fetuins from different species and human alpha 2-HS-glycoprotein Biochemistry 1992, 31 (20) 4915-21
40. Edge, A. S.; Spiro, R. G. Presence of an O-glycosidically linked hexasaccharide in fetuin J. Biol. Chem. 1987, 262 (33) 16135-41
41. Stefan, N.; Haring, H. U. The role of hepatokines in metabolism Nat. Rev. Endocrinol. 2013, 9 (3) 144-52
42. Wang, H.; Sama, A. E. Anti-inflammatory role of fetuin-A in injury and infection Curr. Mol. Med. 2012, 12 (5) 625-33
43. Inohara, H.; Raz, A. Identification of human melanoma cellular and secreted ligands for galectin-3 Biochem. Biophys. Res. Commun. 1994, 201 (3) 1366-75
44. von Mach, T.; Carlsson, M. C.; Straube, T.; Nilsson, U.; Leffler, H.; Jacob, R. Ligand binding and complex formation of galectin-3 is modulated by pH variations Biochem. J. 2014, 457 (1) 107-15
45. Akar, U.; Chaves-Reyez, A.; Barria, M.; Tari, A.; Sanguino, A.; Kondo, Y.; Kondo, S.; Arun, B.; Lopez-Berestein, G.; Ozpolat, B. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells Autophagy 2008, 4 (5) 669-79
46. Ohnishi, T.; Nakamura, O.; Ozawa, M.; Arakaki, N.; Muramatsu, T.; Daikuhara, Y. Molecular cloning and sequence analysis of cDNA for a 59 kD bone sialoprotein of the rat: demonstration that it is a counterpart of human alpha 2-HS glycoprotein and bovine fetuin J. Bone Miner. Res. 1993, 8 (3) 367-77
47. Martin, M. J.; Muotri, A.; Gage, F.; Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid Nat. Med. 2005, 11 (2) 228-32